By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) To Collaborate With The University of Wisconsin And Louvain University In Test Of Hystem®-Based Hydrogel For Vocal Fold Scarring 8/28/2014 10:23:31 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Receives FDA Clearance To Initiate Phase 1/2a Clinical Trial Of AST-OPC1 In Patients With Cervical Complete Spinal Cord Injury 8/27/2014 10:56:06 AM
BioTime (BTX) Announces Second Quarter 2014 Results And Recent Developments 8/12/2014 8:43:59 AM
BioTime (BTX) Receives FDA Premarket Notification Clearance For Premvia™ 510(k) 8/12/2014 8:22:38 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Expands Clinical Development Of Bladder Cancer Diagnostic By Initiating A Large Multi-Site Clinical Trial 7/31/2014 10:56:29 AM
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014 8:22:33 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Announces Investment By CEO 6/17/2014 10:16:15 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Raises $13.0 Million In Equity Financing 6/17/2014 10:14:07 AM
BioTime (BTX) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 6/2/2014 9:04:13 AM
BioTime (BTX)'s Subsidiary Asterias Biotherapeutics Bags $14.3 Million Grant 5/30/2014 6:34:24 AM